Purchase Order HHSN269201600147P
Award Date 12/17/15
Potential Completion Date 12/17/15
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services (HHS) awarded a firm fixed-price Purchase Order contract worth $24,454.50 to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies. This contract, awarded on August 21, 2014, is not set aside for small businesses. Stemcell Technologies Inc. primarily...
- This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
- This federal contract award, valued at $11,170.80, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which is not set aside for small businesses, is for the provision of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various government agencies, particularly within the Department of...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $10,313.00 Firm Fixed Price contract is for the provision of a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various NIH institutes and centers. Stemcell Technologies Inc. holds a single-award...
- This federal contract award was issued by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $24,994.77 firm-fixed-price purchase order, awarded on November 6, 2019, is for the delivery of STEMDIFF APEL 2 MEDIUM, a specialized cell culture product used to support biomedical research initiatives. Stemcell...
- Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company, to provide specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research initiatives across various government agencies. The contract, valued at...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...